Cell Line : 253J-BV
Cellosaurus Index : CVCL_7937
Cellosaurus ID : 253J-BV
CTRP2 Name
: 253JBV
CCLE Name
: 253JBV_URINARY_TRACT
Cancer Type : urinary_tract
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| 253J-BV | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| 253J-BV | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | 968 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | AA-COCF3 | CTRP2 | 0.0081 | 270.0000 |
|
| 253J-BV | ABT737 | CTRP2 | 0.0011 | 37.0000 |
|
| 253J-BV | AC55649 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | Afatinib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | AGK-2 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | Alisertib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| 253J-BV | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 |
|
| 253J-BV | austocystin D | CTRP2 | 0.0011 | 37.0000 |
|
| 253J-BV | Axitinib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | AZD4547 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | AZD6482 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | AZD7762 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | AZD8055 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Bax channel blocker | CTRP2 | 0.0160 | 33.0000 |
|
| 253J-BV | BEC | CTRP2 | 0.0081 | 270.0000 |
|
| 253J-BV | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Bexarotene | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BI-2536 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | BIBR-1532 | CTRP2 | 0.0081 | 270.0000 |
|
| 253J-BV | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BIX-01294 | CTRP2 | 0.0160 | 33.0000 |
|
| 253J-BV | blebbistatin | CTRP2 | 0.0041 | 130.0000 |
|
| 253J-BV | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BMS-536924 | CTRP2 | 0.0011 | 37.0000 |
|
| 253J-BV | BMS-754807 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | Bortezomib | CTRP2 | 0.0000 | 0.1300 |
|
| 253J-BV | Bosutinib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| 253J-BV | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| 253J-BV | BRD-A94377914 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K03911514 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K04800985 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K13185470 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K16130065 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K20514654 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| 253J-BV | BRD-K27188169 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K27188169:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| 253J-BV | BRD-K27224038 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K30019337 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K34099515 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K34222889 | CTRP2 | 0.0017 | 57.0000 |
|
| 253J-BV | BRD-K35604418 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | BRD-K41334119 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K48334597 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K49290616 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K55116708 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K58730230 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| 253J-BV | BRD-K75293299 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K78574327 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K79669418 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K84807411 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K86535717 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| 253J-BV | BRD-K96431673 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K96970199 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD-K99584050 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD4132 | CTRP2 | 0.0049 | 160.0000 |
|
| 253J-BV | BRD4770 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | BRD55319 | CTRP2 | 0.0011 | 37.0000 |
|
| 253J-BV | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | BRD8958 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| 253J-BV | brefeldin A | CTRP2 | 0.0011 | 37.0000 |
|
| 253J-BV | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Cabozantinib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| 253J-BV | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| 253J-BV | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | CD-437 | CTRP2 | 0.0011 | 37.0000 |
|
| 253J-BV | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| 253J-BV | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| 253J-BV | CHIR-99021 | CTRP2 | 0.0024 | 80.0000 |
|
| 253J-BV | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| 253J-BV | CI-976 | CTRP2 | 0.0081 | 270.0000 |
|
| 253J-BV | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | CIL55 | CTRP2 | 0.0003 | 10.0000 |
|
| 253J-BV | CIL55A | CTRP2 | 0.0024 | 80.0000 |
|
| 253J-BV | CIL56 | CTRP2 | 0.0001 | 2.5000 |
|
| 253J-BV | CIL70 | CTRP2 | 0.0012 | 40.0000 |
|
| 253J-BV | cimetidine | CTRP2 | 0.0081 | 270.0000 |
|
| 253J-BV | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Compound 1541A | CTRP2 | 0.0011 | 37.0000 |
|
| 253J-BV | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Compound 7d-cis | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | Crizotinib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| 253J-BV | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| 253J-BV | cyanoquinoline 11 | CTRP2 | 0.0041 | 130.0000 |
|
| 253J-BV | Cyclophosphamide | CTRP2 | 0.0041 | 130.0000 |
|
| 253J-BV | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Daporinad | CTRP2 | 0.0000 | 0.2600 |
|
| 253J-BV | darinaparsin | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | Dasatinib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| 253J-BV | Doramapimod | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Doxorubicin | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | ELCPK | CTRP2 | 0.0000 | 0.4000 |
|
| 253J-BV | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Entinostat | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Erlotinib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| 253J-BV | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| 253J-BV | Etoposide | CTRP2 | 0.0009 | 28.0000 |
|
| 253J-BV | Fedratinib | CTRP2 | 0.0011 | 37.0000 |
|
| 253J-BV | FGIN-1-27 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| 253J-BV | Foretinib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | FQI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | FSC231 | CTRP2 | 0.0081 | 270.0000 |
|
| 253J-BV | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| 253J-BV | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Gefitinib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Gemcitabine | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | GMX-1778 | CTRP2 | 0.0000 | 0.2900 |
|
| 253J-BV | gossypol | CTRP2 | 0.0011 | 37.0000 |
|
| 253J-BV | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| 253J-BV | GW843682X | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | I-BET-762 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | I-BET151 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | ifosfamide | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| 253J-BV | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| 253J-BV | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| 253J-BV | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | KU-55933 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | KU-60019 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | L-685458 | CTRP2 | 0.0011 | 37.0000 |
|
| 253J-BV | Lapatinib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Linifanib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Linsitinib | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| 253J-BV | LY-2157299 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | LY-2183240 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| 253J-BV | Masitinib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | Methotrexate | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| 253J-BV | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | MK-1775 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | ML050 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| 253J-BV | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| 253J-BV | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | myriocin | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | Navitoclax | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 |
|
| 253J-BV | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | neopeltolide | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | Nilotinib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | NPC-26 | CTRP2 | 0.0012 | 20.0000 |
|
| 253J-BV | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| 253J-BV | NSC23766 | CTRP2 | 0.0160 | 530.0000 |
|
| 253J-BV | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | NSC632839 | CTRP2 | 0.0160 | 33.0000 |
|
| 253J-BV | NSC95397 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | Nutlin-3a | CTRP2 | 0.0045 | 150.0000 |
|
| 253J-BV | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | NVP-ADW742 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | NVP-TAE684 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Obatoclax Mesylate | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Olaparib | CTRP2 | 0.0045 | 150.0000 |
|
| 253J-BV | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | OSI-027 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| 253J-BV | Oxaliplatin | CTRP2 | 0.0320 | 66.0000 |
|
| 253J-BV | PAC-1 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | Paclitaxel | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Pazopanib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | PDMP | CTRP2 | 0.0065 | 210.0000 |
|
| 253J-BV | Pevonedistat | CTRP2 | 0.0011 | 37.0000 |
|
| 253J-BV | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | PF-750 | CTRP2 | 0.0081 | 270.0000 |
|
| 253J-BV | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | phloretin | CTRP2 | 0.0180 | 590.0000 |
|
| 253J-BV | PI-103 | CTRP2 | 0.0011 | 37.0000 |
|
| 253J-BV | Pictilisib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | PIK-93 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| 253J-BV | PRIMA-1MET | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| 253J-BV | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | purmorphamine | CTRP2 | 0.0046 | 150.0000 |
|
| 253J-BV | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| 253J-BV | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | QS11 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | Quizartinib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | RAF265 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| 253J-BV | Saracatinib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| 253J-BV | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| 253J-BV | Selisistat | CTRP2 | 0.0024 | 80.0000 |
|
| 253J-BV | Selumetinib | CTRP2 | 0.0081 | 270.0000 |
|
| 253J-BV | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| 253J-BV | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| 253J-BV | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| 253J-BV | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| 253J-BV | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| 253J-BV | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| 253J-BV | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| 253J-BV | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Sepantronium bromide | CTRP2 | 0.0000 | 1.0000 |
|
| 253J-BV | Serdemetan | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | SID 26681509 | CTRP2 | 0.0090 | 300.0000 |
|
| 253J-BV | sildenafil | CTRP2 | 0.0160 | 530.0000 |
|
| 253J-BV | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | simvastatin | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| 253J-BV | sitagliptin | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | SJ-172550 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | SKI-II | CTRP2 | 0.0041 | 130.0000 |
|
| 253J-BV | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | SN-38 | CTRP2 | 0.0000 | 1.3000 |
|
| 253J-BV | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | SNX-2112 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| 253J-BV | Sorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | SU11274 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | tacrolimus | CTRP2 | 0.0023 | 74.0000 |
|
| 253J-BV | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| 253J-BV | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | Temozolomide | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Temsirolimus | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Teniposide | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | tigecycline | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | tipifarnib-P2 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | Tivozanib | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | Topotecan | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | tosedostat | CTRP2 | 0.0081 | 270.0000 |
|
| 253J-BV | TPCA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Tretinoin | CTRP2 | 0.0041 | 130.0000 |
|
| 253J-BV | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| 253J-BV | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| 253J-BV | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | triptolide | CTRP2 | 0.0000 | 0.2900 |
|
| 253J-BV | Tubastatin A | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| 253J-BV | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Veliparib | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| 253J-BV | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| 253J-BV | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | Vorinostat | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0320 | 66.0000 |
|
| 253J-BV | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | YK-4-279 | CTRP2 | 0.0010 | 33.0000 |
|
| 253J-BV | YL54 | CTRP2 | 0.0020 | 66.0000 |
|
| 253J-BV | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| 253J-BV | ZSTK474 | CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC